Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan Jin

Showing results (381-390 of 397) with videos related to

Pageof 40
Sort By:
Cancer|July 20, 2024
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 StudyHyun Cheol Chung, Esma Saada-Bouzid, Federico Longo, et al.
Cancer Causes & Control : CCC|December 17, 2003
A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and teaWendy J Mack, Susan Preston-Martin, Luigino Dal Maso, et al.
Current Pharmaceutical Design|August 6, 2013
Epigenetic inheritance of paternally expressed imprinted genes in the testes of ICSI miceXiang-Rong Xu, Rong-Guo Fu, Li-Ya Wang, et al.
Cancer|February 7, 2023
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 studyDo-Youn Oh, Alain Algazi, Jaume Capdevila, et al.
Cancer Causes & Control : CCC|November 8, 2002
A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables (International)Cristina Bosetti, Eva Negri, Laurence Kolonel, et al.
Nature Cancer|February 20, 2025
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trialAurelien Marabelle, David M O'Malley, Andrew E Hendifar, et al.
Human Reproduction (Oxford, England)|July 18, 2013
Alterations in the frequency of trinucleotide repeat dynamic mutations in offspring conceived through assisted reproductive technologyYing-Ming Zheng, Li Li, Li-Ming Zhou, et al.
Human Genomics|January 5, 2019
Preimplantation genetic diagnosis and screening (PGD/S) using a semiconductor sequencing platformLi-Ya Wang, Xing-Qiang Rao, Yu-Qin Luo, et al.
Future Oncology (London, England)|October 15, 2025
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumorsThomas Powles, Aarti Bhatia, Barbara Burtness, et al.
Cancer|August 14, 2025
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohortSun Young Rha, Eduardo Castanon, Sanjeev Gill, et al.
Pageof 40

Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
Cancer|July 20, 2024
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 StudyHyun Cheol Chung, Esma Saada-Bouzid, Federico Longo, et al.
Cancer Causes & Control : CCC|December 17, 2003
A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and teaWendy J Mack, Susan Preston-Martin, Luigino Dal Maso, et al.
Current Pharmaceutical Design|August 6, 2013
Epigenetic inheritance of paternally expressed imprinted genes in the testes of ICSI miceXiang-Rong Xu, Rong-Guo Fu, Li-Ya Wang, et al.
Cancer|February 7, 2023
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 studyDo-Youn Oh, Alain Algazi, Jaume Capdevila, et al.
Cancer Causes & Control : CCC|November 8, 2002
A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables (International)Cristina Bosetti, Eva Negri, Laurence Kolonel, et al.
Nature Cancer|February 20, 2025
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trialAurelien Marabelle, David M O'Malley, Andrew E Hendifar, et al.
Human Reproduction (Oxford, England)|July 18, 2013
Alterations in the frequency of trinucleotide repeat dynamic mutations in offspring conceived through assisted reproductive technologyYing-Ming Zheng, Li Li, Li-Ming Zhou, et al.
Human Genomics|January 5, 2019
Preimplantation genetic diagnosis and screening (PGD/S) using a semiconductor sequencing platformLi-Ya Wang, Xing-Qiang Rao, Yu-Qin Luo, et al.
Future Oncology (London, England)|October 15, 2025
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumorsThomas Powles, Aarti Bhatia, Barbara Burtness, et al.
Cancer|August 14, 2025
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohortSun Young Rha, Eduardo Castanon, Sanjeev Gill, et al.
Pageof 40